date,title,source
Oct-18-18,"Avinger Receives CE Marking Approval for Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels",ACCESSWIRE
Oct-30-18,Avinger Announces Pricing of $10 Million Underwritten Public Offering,ACCESSWIRE
Nov-01-18,Avinger Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option,ACCESSWIRE
Nov-05-18,"Avinger to Announce Third Quarter 2018 Financial Results on November 13, 2018",ACCESSWIRE
Nov-07-18,Avinger to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2018,ACCESSWIRE
Nov-13-18,Avinger Provides Third Quarter 2018 Shareholder Update,ACCESSWIRE
Nov-14-18,Avinger: 3Q Earnings Snapshot,Associated Press
Nov-14-18,Edited Transcript of AVGR earnings conference call or presentation 13-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-15-18,"Avinger Announces Successful Treatment of First Patients Globally with Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels",ACCESSWIRE
